Viral Hepatitis: Types, Symptoms & Treatment

Viral hepatitis is an inflammatory condition of the liver, predominantly caused by infections. However, other factors such as excessive alcohol consumption, certain medications and autoimmune diseases can also induce hepatitis. Much like any disease, identifying the signs of hepatitis helps tremendously in the rapid intervention and treatment.

Table of Contents

• Types of Hepatitis
• Hepatitis Causes and Transmission
• Symptoms of Hepatitis
• Diagnosis
• Hepatitis Treatment
• Prevention
• Global Impact
• Challenges and Future Directions
• Conclusion
• More Information

Types of Hepatitis

Hepatitis is broadly classified into five main types: A, B, C, D and E.

Hepatitis A

Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus (HAV). It is usually transmitted through ingestion of contaminated food or water. Poor sanitation and hygiene practices significantly contribute to its spread. The disease typically presents with flu-like symptoms and jaundice. Fortunately, it does not lead to chronic liver disease and is preventable through vaccination.

Hepatitis B

Hepatitis B, caused by the hepatitis B virus (HBV), is a serious liver infection that can become chronic, leading to liver failure, cirrhosis or liver cancer. It spreads through contact with infectious body fluids, such as blood, semen and vaginal secretions. Mother-to-child transmission during childbirth also occurs. Vaccination is available and is highly effective in preventing HBV infection. 

Hepatitis C

Hepatitis C is caused by the hepatitis C virus (HCV) and is primarily transmitted through blood-to-blood contact. This can occur via shared needles among drug users, non-sterile medical equipment and transfusions of unscreened blood. Unlike hepatitis B, there is no vaccine for hepatitis C, but antiviral hepatitis treatment can cure most cases. 

Hepatitis D

Hepatitis D, or “delta hepatitis”, is a liver infection caused by the hepatitis D virus (HDV), a defective virus that requires the presence of hepatitis B to replicate. It is transmitted through contact with infected blood. Co-infection with HBV and HDV often leads to a more severe disease than HBV infection alone. Prevention of HDV relies on hepatitis B vaccination.

Hepatitis E

Hepatitis E is caused by the hepatitis E virus (HEV) and is typically spread through ingestion of faecally contaminated water. It is common in areas with poor sanitation. However, it can be severe in pregnant women, leading to acute liver failure. A vaccine is available but not widely used outside of endemic areas. 

Hepatitis Causes and Transmission

Hepatitis causes include viral infections, alcohol abuse, toxins, certain medications, and autoimmune diseases. The most common cause is viral infection, with hepatitis A, B, C, D, and E viruses being the primary culprits. 

Hepatitis A and E:

Spread via the faecal-oral route, typically through contaminated food or water. 

Hepatitis B, C and D:

Spread through exposure to infectious body fluids. This includes blood transfusions, shared needles, sexual contact and from mother to child during childbirth. 

Symptoms

The symptoms of hepatitis can vary widely depending on the type and stage of the infection. Common symptoms include: 

Acute Phase

Fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-coloured stools, joint pain and jaundice (yellowing of the skin and eyes). 

Chronic Phase

Many individuals with chronic hepatitis B or C may remain asymptomatic for years. When symptoms do appear, they are often indicative of advanced liver disease, such as cirrhosis or liver cancer. These symptoms may include prolonged fatigue, jaundice, swelling in the legs and abdomen, and easy bruising or bleeding. 

Diagnosis

Diagnosis of hepatitis involves a combination of medical history, physical examination and various laboratory tests. Key diagnostic tools include: 

Blood Tests

These detect the presence of hepatitis viruses or the antibodies produced in response to infection. Liver function tests (LFTs) assess the extent of liver damage. 

Imaging

Ultrasounds, CT scans and MRIs can help visualise liver damage. 

Liver Biopsy

A small sample of liver tissue is examined under a microscope to assess the degree of liver inflammation and fibrosis. 

Hepatitis Treatment

Hepatitis treatment depends on the type and severity of the infection:

Hepatitis A and E:

These types usually do not require specific antiviral treatment. Supportive care, including rest, adequate nutrition and hydration, is essential. In severe cases, particularly with hepatitis E in pregnant women, hospitalisation may be required. 

Hepatitis B:

Antiviral medications can help “reduce viral load” and slow the progression of liver damage. 

Hepatitis C:

Direct-acting antivirals (DAAs) have revolutionised the treatment of hepatitis C, offering high cure rates with fewer side effects. Treatment regimens vary based on the specific genotype of the virus.

Hepatitis D:

The treatment for hepatitis D is challenging due to the reliance on HBV co-infection. Supportive care: 

In all cases of hepatitis, supportive care is crucial. This includes avoiding alcohol, maintaining a healthy diet and managing symptoms such as itching and nausea. 

Prevention

Preventing hepatitis involves several strategies, including vaccination, safe practices and public health measures:

Vaccination:

Hepatitis vaccines are available for hepatitis A and B. The hepatitis B vaccine also protects against hepatitis D. Routine immunisation, particularly in high-risk groups and in countries with high prevalence, is vital.

Safe practices:

Implementing safe injection practices, screening blood donations, and promoting safe sex can significantly reduce the transmission of hepatitis B and C.

Public health measures:

Ensuring access to clean water and proper sanitation can prevent hepatitis A and E outbreaks. Public awareness campaigns and education on hygiene and safe practices are essential.

Global Impact

Hepatitis remains a significant global health challenge. According to the World Health Organization (WHO), an estimated 325 million people worldwide live with chronic hepatitis B or C, leading to approximately 1.34 million deaths annually from liver cirrhosis and liver cancer. 

Hepatitis B:

Despite the availability of a hepatitis vaccine, hepatitis B remains endemic in many regions, particularly in Sub-Saharan Africa and East Asia. Transmission from mother to child is a major route of infection in these areas. 

Hepatitis C:

The prevalence of hepatitis C is higher in certain regions, such as Eastern Europe, Central Asia and Egypt. The introduction of DAAs has dramatically improved treatment outcomes, but access to these medications remains limited in many low- and middle-income countries. 

Hepatitis A and E:

These types are more common in areas with poor sanitation and limited access to clean water. Outbreaks can occur in both developing and developed countries, often linked to contaminated food or water sources. 

Challenges and Future Directions

Despite advancements in the understanding and management of hepatitis, several challenges remain:

Access to Treatment:

Ensuring access to affordable antiviral medications, particularly in low-resource settings, is crucial. Efforts to negotiate lower drug prices and increase generic production are ongoing.

Vaccination Coverage:

Increasing global vaccination coverage, especially in regions with high hepatitis B prevalence, is essential. Strategies to improve vaccine uptake and integrate hepatitis vaccination into routine immunisation programmes are needed.

Public Awareness:

Enhancing public awareness and education about hepatitis transmission, prevention and treatment can help reduce stigma and encourage testing and vaccination.

Research and Innovation:

Continued research into new treatments, vaccines and diagnostic tools is vital. Innovations in hepatitis B functional cures and hepatitis C vaccines hold promise for the future.

Integrated Approaches:

Addressing hepatitis requires approaches that combine prevention, testing, treatment and care. Strengthening health systems and advocating for international collaboration are key to achieving global hepatitis elimination goals. 

Conclusion

Hepatitis is a complex and multifaceted disease that poses significant health challenges worldwide. Through a combination of vaccination, safe practices, public health measures and access to effective treatments, the burden of hepatitis can be significantly reduced. Continued efforts in research, public awareness and healthcare provision are essential to combat this disease and move towards the ultimate goal of hepatitis elimination.

More Information

For more information, please contact:

Dr R Dabah
Discipline: Gastroenterologist, Physician
Hospital: MooiMed Private Hospital
Telephone: +27 71 659 8200